Capstan Medical
Capstan Medical raises $110M Series C at $600M valuation
Quick Facts
Capstan Medical: Series C Funding Round
Capstan Medical has successfully raised $110M in Series C funding, reaching a valuation of $600M.
Company Overview
Robotic minimally invasive heart valve technology
Funding Details
The Series C round was led by Eclipse Ventures, with participation from Cormorant Asset Management.
Company Information
- Headquarters: Campbell, CA
- Founded: 2018
- Employees: 90+
- Category: MedTech
Investment
Capstan Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Eclipse Ventures: Verified investor in Series C
- Cormorant Asset Management: Verified investor in Series C
Key Investors
About the Author
Related Company Reports
NeuroLink Brain Raises $580M Series D to Transform Healthcare
NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.
MedTech Revolution Secures $890M Series D to Lead MedTech Innovation
MedTech Revolution raises $890M in Series D funding at $13.7B valuation to complete clinical trials for 5 medical devices, scale robotic surgery systems, and expand to asian markets.
ForSight Robotics raises $125M Series B at $700M valuation
ForSight Robotics raises $125M in Series B at $700M valuation. Ophthalmic surgical robots...